Infornation on the natural history The first systematic account of atrial septal defect in 1934, which was an analysis of 62 post-mortem cases collected from published reports, examined information on the natural history in relation to clinical features,7 including precordial bulging and various systolic and diastolic murmurs attributed to associated mitral or tricuspid valve disease. Death, at an average age of 36 years, usually resulted from cardiac failure, often associated with atrial fibrillation. A much clearer and more detailed description of the clinical features, which appeared in 1941,8 was an important landmark because it demonstrated that atrial septal defect was a specific clinical entity that could be diagnosed at the bedside with the aid of simple tests. Bedford et al detailed the classic radiological features of cardiomegaly, enlarged pulmonary arteries, hilar pulsation, and a small aortic knuckle that had been defined over the preceding 10 years7 and summarised the electrocardiographic changes. They did not attempt to define the natural history but they did remark that most patients were breathless, that cardiac failure was rare before the third decade, and that when it occurred it was preceded by a period of 10-20 years of increasing exertional dyspnoea. The first reports written by Campbell et al with the specific objective of describing the natural history of atrial septal defects910 appeared in response to the article by Bedford et al. Campbell et al were particularly struck by the fact that during the first two decades of life though most patients had cardiomegaly their symptoms were mild and non-progressive. With one exception, a girl with mitral regurgitation, they had normal pulmonary artery pressures despite having large shunts. By the third decade, however, approximately a third of patients reported increasing breathlessness and some had a raised pulmonary artery pressure. This pattern of progressive disability continued and cardiac failure, atrial fibrillation, and pulmonary hypertension were increasingly common. Half the patients had symptoms by the age of 40 common. They noted, however, that "the great majority of patients did not consider themselves disabled and engaged easily in ordinary activities". This discrepancy between the subjective and objective assessment of symptoms goes some way towards explaining the wide variation in the reported incidence of symptoms. The pulmonary artery systolic pressure was greater than 25 mm Hg in 60% of cases but only 15% had obstructive pulmonary hypertension (pulmonary vascular resistance > 5 units) this low percentage, compared with ventricular septal defect and patent ductus arteriosus has been noted by others.'314 The general observations of Craig and Selzer regarding progressive deterioration were similar to those of the earlier studies, although they concluded that pulmonary hypertension was the commonest single factor to presage worsening symptoms.
Shortcomings of the data on natural history Though a fairly consistent clinical pattern emerges from these studies of the natural history of atrial septal defect, the data on which it is based are deficient. There are two major sources of error. Firstly, data relate predominantly to sick patients and secondly follow up information is inadequate. Patients were recruited for these early studies in the 1940s and 50s when the clinical recognition of atrial septal defect was in its infancy as was surgical treatment. It was therefore inevitable that the cases studied would be the most clinically obvious: for example most of the young patients had symptoms, albeit mild, whereas some later surgical series, which incorporated a wider range of cases, reported that most children were symptom free,'5 and even in adult surgical series 50-70% were only mildly restricted'6 or not at all restricted.' It was acknowledged that "the patients are far from the ideal of an unselected community"'0 and "small shunts cannot be clinically recognised, all patients had haemodynamically significant lesions".'2 Even today it is accepted that the clinical diagnosis of the small atrial septal defect is difficult and many patients are referred to cardiac centres without a diagnosis, unless echocardiography has been performed. In two of the reports9 12 there was no follow up of patients: in one of these'2 the authors "reconstructed the natural history" from their own observations and from other studies, notably those already quoted here. Campbell calculated mortality from patientyears of observation but the mean duration of follow up was only about 5-2 years.'0 The duration of follow up in the other series" was similar, and many of the patients were untraceable: 67 patients were seen at the age of 41-45 but only 47 aged 46-50 and eight in the over 60 age group, though during this period only 11 were known to have died. Our understanding of the natural history of atrial septal defect is therefore based on an analysis of predominantly symptomatic patients who were either examined on a single occasion or were followed up for about five years. Conclusions drawn from such data must be guarded and are not applicable to unselected patients. We have no information on the long-term prognosis of symptom free children who are perhaps in the majority. '5 Furthermore, the best information we have on symptom free adults with atrial septal defect comes from the accompanying report on page 224 from a major referral centre that would have attracted a selected patient population. Two potential sources of information on the incidence of small or asymptomatic atrial septal defects in an unselected adult population proved to be unhelpful. Firstly, an Australian case finding study based on miniature mass radiology, detected no examples of atrial septal defect in 111 000 people aged over 65 years.'7 The conclusion that this confirms the rarity of survival to this age'2 is not justified for several reasons: (a) some patients with an atrial septal defect have a normal chest x ray, (b) about 20-25% of the population of Australia at that time were immigrants'8 who had undergone chest x ray examination before entry visas were granted, (c) Brigden reported that two out of 52 patients detected by miniature mass radiology were aged over 60 years,8 (d) Up to 30% of adults with atrial septal defect have atypical radiological features.'9 Also the incidence of atrial septal defect in routine postmortem examinations of adults is unknown.
Causes of symptomatic deterioration and pathophysiology Although there are major gaps in the data on natural history it is valid to conclude that symptomatic patients become progressively more limited as they age (what is not known is the percentage of patients to whom this applies). Symptomatic deterioration has been attributed to the size of the defect,8 pulmonary hypertension, 12 39 40 In some reports, cardiac failure and pulmonary hypertension were associated with operative mortalities of 10-50%4344 and even in more recent studies most operative deaths have been in these groups. In the comprehensive report by Murphy et al"3 the operative mortality was 3-3% and all those who died were aged over 40 years. Not only is the operative mortality higher in adults than in children but late complications are more common and long-term survival is less than in controls. The actuarial survival at 27 years for patients operated on over the age of 25 was 40% compared with 59% for controls."3 Fifty nine per cent of patients in this age group had late events compared with 15% in younger patients: 42% of these complications were due to cardiac failure, 25% of patients had an embolic stroke (all were in atrial fibrillation) and 15% had either complete heart block or required pacemaker implantation. Others have also observed a high incidence of late embolic events. 4045 Despite the frequency of complications it has been concluded that surgically treated patients fare better than those treated medically. The evidence on which this conclusion is based does not stand up to close scrutiny. Firstly, these were not controlled studies and with one exception37 none of the authors indicated whether patients with advanced disease or with other complications were excluded from surgery. Secondly, at least with respect to symptoms, patients in the different surgical series were not comparable: the incidence of severe preoperative limitations ranged from 50% to 100%. Furthermore, the symptomatic status of patients in the surgical and medical (natural history) series was different. This difficulty is compounded because not all authors used the New York Heart Association system: some simply quoted the incidence of symptoms.9 13 It is clear, however, that patients in some surgical series'6 were significantly less symptomatic than medically treated patients." Other aspects of data presentation in the surgical reports preclude objective comparisons. Preoperative haemodynamic data are presented in different formats or not at all,38 the follow up period is variable, sometimes brief46 or not stated,44 and finally some authors do not mention postoperative complications such as atrial fibrillation, cardiac failure, and strokes.33 44 46 In addition to these criticisms the longterm outcome in surgical series was always compared (favourably) with the previously discussed inadequate studies of natural history.
Two earlier reports also based their conclusions regarding appropriate treatment on a comparison of medically and surgically treated cases.1444 Steele et al found that after a minimum follow up of four years 20% of surgically treated patients and 71% of medical patients had died.'4 Not surprisingly they concluded that, except for those in whom pulmonary vascular resistance was > 10 units, surgery was the correct treatment. In the study reported by Wolf et al 20% of the surgical group died post operatively (most operations were done before the introduction of cardiopulmonary bypass), 25% died later, but 50% were improved. 44 After an unstated time, 68% of traceable medical cases (11 of 16) were alive, nine of whom had minimal or no symptoms. In both of these studies patients in the medical group were more seriously ill. Despite deficiencies in the data, their conclusion,44 that surgical mortality in patients with severe pulmonary hypertension is high, is widely accepted. Their other conclusion, that symptom free adults may fare better with medical treatment, now finds support from Shah et al.I Shah et al compared broadly similar groups of medically and surgically treated adults followed for 20 years. This was possible because for many years one of the authors did not routinely advise surgery. Patients in the surgical group had less severe symptoms than those in most previous reports, and this may explain the apparent lack of benefit from operative treatment. Surgical patients fared no better over the 20 years of follow up than medical cases with respect to mortality and to the incidence of breathlessness, atrial fibrillation, emboli, and cardiac failure. However assessment of the data on which the conventional policy is based.
In brief, neither the data on natural history nor the morbidity and survival figures from surgical results discussed here justify the claim that operation is better than conservative management.
Conclusions
There is objective evidence from the data on natural history and from surgical reports to justify repair of atrial septal defect in children with symptoms. This will restore functional capacity and life expectancy to normal at a very low operative mortality with only a small percentage developing late complications. Because we do not know the natural history of the condition in symptom free children there is no evidence that they should have surgery. They should, however, be reviewed annually to detect the onset of symptoms, which should be assessed objectively, and have echocardiography to indicate whether the shunt is increasing or whether pulmonary hypertension is developing. The onset of symptoms or of haemodynamic deterioration would warrant surgery. The age beybnd which surgery should not be routinely offered is uncertain because the situation in adults is less clear than in children. However, it appears that surgery only restores life expectancy to normal before the age of 25"3 and beyond that age, certainly in the less severely affected patients (in terms of symptoms and pulmonary artery pressure), surgery may offer no advantage.'
A rational approach to the management of atrial septal defect in adults, in particular those with symptoms, requires a controlled assessment of the relative merits of medical and surgical treatment.
